TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest. November 22, 2006
TCL Archive In Brief: Elion Elected Member Of National Academy; Bleyer Heads M.D. Anderson Pediatrics May 4, 1990
